ArticleCell reports2022

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants.

Jeffrey Seow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.